What does SUTRO BIOPHARMA, INC. (STRO) do?

SUTRO BIOPHARMA, INC. (STRO) is a publicly traded company.

What sector does STRO operate in?

SUTRO BIOPHARMA, INC. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find STRO earnings analysis?

AlphaOS publishes an earnings intelligence page for SUTRO BIOPHARMA, INC. (STRO) covering results, guidance context, and AI-assisted analysis. See /stocks/STRO/earnings. Content is for research and education — not investment advice.

STRO

SUTRO BIOPHARMA, INC.

$16.03Sep 28, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

SUTRO BIOPHARMA, INC. shows decelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.

Why it matters: Revenue -85% YoY in Q2 FY2026.

TrajectoryDecelerating

ExecutionMixed

2 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -85% YoY in Q2 FY2026

Pipeline evidence · 1d ago

STRO's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on STRO.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full STRO earnings analysis

Reported figures for SUTRO BIOPHARMA, INC. — research only, not investment advice.

Revenue YoY: -84.6%

Latest Intelligence

Updated September 29, 2026

What happened recently for SUTRO BIOPHARMA, INC. (STRO) — events, not interpretation.

Event: Reported Q2 2026 revenue -85% YoY.
Also: Last session September 28, 2026 at $16.03.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

SUTRO BIOPHARMA, INC. (STRO)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for SUTRO BIOPHARMA, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:: $265.80M
Revenue:: $11.30M

STRO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow SUTRO BIOPHARMA, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.